Thanks Dan. Excited to see it in print. Linking my prior tweets describing this work. twitter.com/adamssperling/…

data is my passion

Really important paper in print today by Adam Sperling, MD, PhD and colleagues on Revlimid and p53 mutations that cause therapy-related myeloid neoplasms ashpublications.org/blood/article-…

I’m really pleased to share this paper from Erica Barnell et al on Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma. 1/n ashpublications.org/bloodadvances/…

Functional genomics screens and #DepMap data identified STUB1 ubiquitin ligase/CHIC2 protein complex as negative regulators of IL-3, IL-5, and GM-CSF cytokine receptor common β chain (CSF2RB) stability.
sciencedirect.com/science/articl…. Led by Sebastian Koochaki, Ebert Lab - Fischer Lab

Drs. Grunstein and Allis receiving Albany Med Prize this morning. Congratulations!!🎉🎊🎈

A phase 1 clinical trial co-led by our Dana-Farber colleague Dr. Eric Smith showed for the first time that a CAR T-cell therapy targeting the GPRC5D antigen can produce a strong response among patients with resistant multiple myeloma. dana-farber.org/newsroom/news-…

Warmest congratulations to Michael Grunstein and David Allis for receiving the 2022 Albany Prize given by ⁦⁦Albany Med⁩! We are extremely proud of the pioneering research on histones that Michael conducted ⁦David Geffen School of Medicine at UCLA⁩ and our Department! timesunion.com/news/article/T…

As NY celebrates Aaron Judge’s 61st home run, the bigger NY/BOS matchup is tonight with Memorial Sloan Kettering Cancer Center and Dana-Farber going head to head discussing all the hot topics in MM and CML! Register now! cvent.me/3rnx9Y #mmsm Clifton Mo Shonali Midha, M.D. Saad Z. Usmani MD MBA FACP (he/his/him)

Our report of first-in-human GPRC5D-targeted CAR T cells for MM is out in NEJM! The trial was led by Sham Mailankody and could not be done without the amazing clinical, correlative science, stats, & cell manufacturing teams.
Happy to share our bench>bedside journey
1/10

Very excited to see this incredible work led by Sham Mailankody and Eric Smith published in NEJM. An incredible bench-to-bedside story leading to real progress for our patients. Looking forward to seeing what comes next. nejm.org/doi/full/10.10…

We are looking for postdocs or graduate students BBS at Harvard to join our team! If you're interested in applying functional genetics/integrative genomics to study cancer, please contact me. Check out lab website viswanathanlab.dana-farber.org or apply here: careers-dfci.icims.com/jobs/31228/res…

Please join us for this really important endeavor 👇🏽with academia, industry and the fda with superb discussions with Vincent Rajkumar Sagar Lonial MD Shaji Kumar Saad Z. Usmani MD MBA FACP (he/his/him) to name a few.. will hopefully pave the way for more efficient approval strategies for #mmsm

Really fantastic work.

An interesting strategy - public voting on the finalists of a science award. Support Sandra McAllister and Dr. E Mittendorf so they can help Black breast cancer patients Brigham and Women's Hospital discoverbrigham.org/bri/awards-fun…